Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 1,667 | 7,771 | 8,595 | 7,868 | 10,861 |
| Cost of Goods | 2,931 | 2,737 | 20,438 | 4,287 | 12,490 |
| Gross Profit | -1,264 | 5,034 | -11,843 | 3,581 | -1,629 |
| Operating Expenses | 52,238 | 70,054 | 148,682 | 67,129 | 381,195 |
| Operating Income | -52,571 | -64,283 | -160,087 | -63,261 | -382,334 |
| Interest Expense | 12,108 | 12,077 | 11,811 | 11,810 | 12,521 |
| Other Income | -2,167 | -27,392 | 5,514 | 1,217 | 1,790 |
| Pre-tax Income | -66,846 | -103,752 | -166,384 | -73,854 | -393,065 |
| Income Tax | -12,393 | -18,916 | -6,968 | -66,636 | -23,000 |
| Net Income Continuous | -54,453 | -84,836 | -159,416 | -7,218 | -370,065 |
| Net Income Discontinuous | 256 | 113,985 | -18,846 | -22,957 | -27,203 |
| Net Income | $-54,197 | $29,149 | $-178,262 | $-30,175 | $-397,268 |
| EPS Basic Total Ops | -0.74 | 0.39 | -2.45 | -0.42 | -5.53 |
| EPS Basic Continuous Ops | -0.74 | -1.15 | -2.19 | -0.10 | -5.15 |
| EPS Basic Discontinuous Ops | 0.00 | 1.54 | -0.26 | -0.32 | -0.38 |
| EPS Diluted Total Ops | -0.74 | 0.39 | -2.45 | -0.42 | -5.53 |
| EPS Diluted Continuous Ops | -0.74 | -1.15 | -2.19 | -0.10 | -5.15 |
| EPS Diluted Discontinuous Ops | 0.00 | 1.54 | -0.26 | -0.32 | -0.38 |
| EPS Diluted Before Non-Recurring Items | -0.67 | -0.80 | N/A | N/A | N/A |
| EBITDA(a) | $-45,070 | $-56,810 | $-149,244 | $-50,811 | $-371,788 |